We retrospectively assessed the efficacy of TTF-1, CK7, P63, P40, and Napsin A, IHC markers in differentiating and sub-classifying ADC, NSCLC, and SCC on TCBs to determine the accuracy of the tumour markers. The gene discussed is NAPSA; the disease is non-small cell lung carcinoma.